Clinical Trials Directory

Trials / Unknown

UnknownNCT04668027

Impulse Oscillation to Evaluate Diagnostic Efficacy in Patients With Chronic Airway Disease

Evaluating the Efficacy of Impulse Oscillation Before and After Bronchial Provocation Test and Bronchial Dilation Test in Patients With Chronic Airway Disease

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
172 (estimated)
Sponsor
Zhujiang Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

The aim of the research is to explore the diagnostic efficacy of impulse oscillation (IOS) before and after bronchial provocation test (BPT) and bronchial dilation test (BDT) in chronic airway disease.

Detailed description

The present study has the following objectives: to explore the diagnostic value of IOS before and after BPT/BDT in chronic airway disease, to assess the diagnostic accuracy of IOS in chronic airway disease with special regard to its discriminating value between asthma and chronic obstructive pulmonary disease, to evaluate the characteristics of airway resistance after BPT/BDT, to evaluate the airway reversibility and hyperresponsiveness(AHR)in asthma.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTimpulse oscillation(IOS)The patient is tested for the first IOS after the screening test, and performed the second IOS test immediately after the results of BPT or BDT. The patient takes seats, body relax, make sure the mouthpiece is fully covered by mouth, then clip nose with both hands to cover both sides of the cheek, and then calms breathing one minutes.
DIAGNOSTIC_TESTbronchial provocation test(BPT)Patient needs to cooperate with the inhalation of acetylcholine stimulants with low to high concentrations, and operates in accordance with the standard nebulized administration procedure. Measure FEV1 after each inhalation and take the high value. The interval between the inhalation of two adjacent doses is 5 minutes, until the FEV1 decrease value is ≥20% of the FEV1 base value or the highest inhalation concentration. The patient needs to cooperate to ensure that the filter is as tight as possible to prevent air leakage, and performs exhalation and inhalation with the greatest strength and fastest speed. After the examination,the patient should inhale the bronchodilator salbutamol sulfate (400ug).
DIAGNOSTIC_TESTbronchial dilation test(BDT)The patient inhales the salbutamol sulfate (400ug). 15 minutes later, the pulmonary function tester is used for measurement. The patient needs to cooperate to ensure that the filter is as tight as possible to prevent air leakage, and to exhale and breathe with the greatest strength and fastest speed. Inhale.

Timeline

Start date
2020-01-01
Primary completion
2022-06-01
Completion
2022-06-01
First posted
2020-12-16
Last updated
2021-08-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04668027. Inclusion in this directory is not an endorsement.